Table 3B.
Therapeutic efficacy of exercise therapy before and 3 months after starting treatment
| Parameter | Before |
3 months after starting treatment |
Significance |
| VAS | 70.6 ± 3.86 | 30.4 ± 9.24 | S.D (p = 0.0011) |
| RDQ | 7.86 ± 1.35 | 3.92 ± 1.25 | S.D (p = 0.0426) |
| SF-36 (eight scaled scores) | |||
| 1) physical functioning | 34.8 ± 4.81 | 46.0 ± 2.51 | N.S (p = 0.1232) |
| 2) role physical | 33.4 ± 4.45 | 44.0 ± 4.07 | N.S (p = 0.1378) |
| 3) bodily pain | 35.1 ± 2.04 | 41.9 ± 2.75 | S.D (p = 0.0325) |
| 4) general health | 42.5 ± 2.98 | 44.9 ± 3.75 | N.S (p = 0.2243) |
| 5) vitality | 43.7 ± 2.81 | 48.4 ± 3.56 | N.S (p = 0.0655) |
| 6) social functioning | 45.6 ± 3.68 | 50.0 ± 2.86 | N.S (p = 0.1192) |
| 7) role emotional | 37.6 ± 4.23 | 48.8 ± 2.71 | N.S (p = 0.0675) |
| 8) mental health | 44.3 ± 3.05 | 50.9 ± 4.06 | N.S (p = 0.0617) |
Data are the mean ± standard error or the number unless otherwise indicated.
N.S: Not significant
NSAID: Nonsteroidal anti-inflammatory drug
RDQ: Roland Morris Disability Questionnaire score
S.D: Significant difference
SF-36: 36-Item Short-Form Health Survey
VAS: Visual analog scale